50 Infos zu Peter Lebowitz

11 Aktuelle Nachrichten

BioPharma

War on Cancer

Peter Lebowitz : Essentially our approach is massive parallel development. When we commit to a program, we commit to covering all lines of therapy and the  ...

Johnson & Johnson Innovation, Boston and Janssen Biotech, Inc. announced a three-year immuno-oncology lung cancer collaboration with the Dana-Farber Cancer...

2  Bilder zu Peter Lebowitz

2 Business-Profile

· At Janssen, Peter Lebowitz has 181 colleagues including Jennifer Taubert (Worldwide Chairman), Linda Fedow (Comm & Public Affairs)… Industry Colleagues. In the Biotechnology industry, Peter Lebowitz has 26,590 colleagues in 2,079 companies located in 42 countries. 14,075 executive movements have been recorded in the last 12 months.

1 Angaben zur Herkunft

View Peter Lebowitz's US census record to find family members, occupation details & more. Access is free so discover Peter Lebowitz's story today.

5 Bücher zum Namen

Peter Lebowitz is the author of Hematology - Oncology Therapy (4.00 avg rating, 1 rating, 0 reviews, published 2006) and Hematology - Oncology Therapy (0...

Peter Lebowitz, M.D., Ph.D., vice president of signal transduction drug discovery. AstraZeneca is developing an inhibitor of MEK, which lies directly downstream ...

Thorough, in-depth treatment, expert analysis of the issues, laws, regulations, cases and rulings that govern federal income taxation of operations involving...

7681 Cole Peter, Lebowitz Robert, Hart Robert, Teaching Hebrew with the aid of computers; the Illinois program: CompHum 18 (Osprey 1984)

2 Dokumente

FOR IMMEDIATE RELEASE Contact: Peter Lebowitz Big Smith Brands, Inc. (561) Peter Cullum/Dan Burris Donley Communications (212)

UroToday - GU OncToday brings coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of GU oncology and urology.

20 Webfunde aus dem Netz

Dr. Peter Lebowitz, MD is an oncologist in Wynnewood, Pennsylvania.

Neurotree: search results

... Klinikum Rechts der Isar, Technische Universität MünchenMünchen, ... Georgina V Long, Igor Puzanov, Peter Lebowitz, Ajay Singh, Shonda Little, ...

Johnson & Johnson Innovation, Boston and Janssen Biotech, Inc. recently announced a 3-year immuno-oncology lung cancer collaboration with the

Expert

... Infante, Michael Millward, Anna C. Pavlick, Steven J. O'Day, Samuel C. Blackman, C. Martin Curtis, Peter Lebowitz, Bo Ma, Daniele Ouellet, Richard F. Kefford.

... urothelial carcinoma, and we have worked expeditiously to develop Balversa for patients in close consultation with the FDA,” Peter Lebowitz, ...

Janssen to Present Data from Robust Oncology Portfolio and Pipeline at the ASCO Annual Meeting, Including Best of ASCO Selections - read this article...

J&J's Janssen acquires cancer-killing virus tech - Drug Delivery Business

Peter Lebowitz, MD, PhD (Janssen Research & Development) Bert Vogelstein, MD (Johns Hopkins School of Medicine; Howard Hughes ...

Janssen Submits New Drug Application to U.S. FDA Seeking Approval of Erdafitinib for the Treatment of Metastatic Urothelial Cancer

The FDA has received a new drug application for erdafitinib as a treatment for patients with locally advanced or metastatic urothelial carcinoma and...